Evidence map›Paper›PMID 28233001›Full record

ArticleLab on a chip2017

Subcellular probes for neurochemical recording from multiple brain sites.

Helen N Schwerdt, Min Jung Kim, Satoko Amemori, Daigo Homma, Tomoko Yoshida, Hideki Shimazu, Harshita Yerramreddy, Ekin Karasan, Robert Langer, Ann M Graybiel and 1 more

Abstract read
In one paragraph

Article in Lab on a chip, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Helen N SchwerdtKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Bldg 76 Room 653G, Cambridge, MA 02139, USA. mjcima@mit.edu and McGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.ORCID 0000-0002-0389-982X
Min Jung KimMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Satoko AmemoriMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Daigo HommaMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Tomoko YoshidaMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Hideki ShimazuMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Harshita YerramreddyMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Ekin KarasanMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Robert LangerKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Bldg 76 Room 653G, Cambridge, MA 02139, USA. mjcima@mit.edu and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Ann M GraybielMcGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Michael J CimaKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Bldg 76 Room 653G, Cambridge, MA 02139, USA. mjcima@mit.edu and Department of Materials Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
McGovern Institute for Brain Research · USMassachusetts Institute of Technology · US

Funding

STUDIES ON THE EXTRAPYRAMIDAL SYSTEMR01NS025529 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GRAYBIEL, ANN M · 1988 to 2017
$5.6M
A New Device for Electrical & Chemical Modulation of Pathological Neural ActivityR01EB016101 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CIMA, MICHAEL J, GRAYBIEL, ANN M · 2013 to 2017
$5.5M
Therapeutic devices for probing electrical and chemical activity in deep brain disordersF32NS093897 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SCHWERDT, HELEN N · 2015 to 2018
$154k
NIBIB NIH HHS R01 EB016101NINDS NIH HHS F32 NS093897NINDS NIH HHS R01 NS025529
6 · The paper itself

Abstract

Dysregulation of neurochemicals, in particular, dopamine, is epitomized in numerous debilitating disorders that impair normal movement and mood aspects of our everyday behavior. Neurochemical transmission is a neuron-specific process, and further exhibits region-specific signaling in the brain. Tools are needed to monitor the heterogeneous spatiotemporal dynamics of dopamine neurotransmission without compromising the physiological processes of the neuronal environment. We developed neurochemical probes that are ten times smaller than any existing dopamine sensor, based on the size of the entire implanted shaft and its sensing tip. The microfabricated probe occupies a spatial footprint (9 μm) coordinate with the average size of individual neuronal cells (∼10 μm). These cellular-scale probes were shown to reduce inflammatory response of the implanted brain tissue environment. The probes are further configured in the form of a microarray to permit electrochemical sampling of dopamine and other neurotransmitters at unprecedented spatial densities and distributions. Dopamine recording was performed concurrently from up to 16 sites in the striatum of rats, revealing a remarkable spatiotemporal contrast in dopamine transmission as well as site-specific pharmacological modulation. Collectively, the reported platform endeavors to enable high density mapping of the chemical messengers fundamentally involved in neuronal communication through the use of minimally invasive probes that help preserve the neuronal viability of the implant environment.

Indexed as

AnimalsBrainBrain ChemistryDopamineElectric StimulationElectrodes, ImplantedMaleMolecular ProbesNeurochemistryNeurotransmitter AgentsRatsDopamineMolecular ProbesNeurotransmitter Agents

Identifiers

PMID28233001
PMCPMC5572650
OpenAlexW2588055353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.